MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02228nam a22002897i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
4175 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240720152448.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160505b2011 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789241209618 |
| 040 ## - CATALOGING SOURCE |
|---|
| Description conventions |
rda |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Language of cataloging |
eng |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
WHO RA 189 .W475 2011 |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
WHO Expert Committee on Specifications for Pharmaceutical Preparations : |
| Remainder of title |
Forty-fifth report. |
| 264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Geneva : |
| Name of producer, publisher, distributor, manufacturer |
World Health Organization, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 461 pages : illustration ; 24 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
Text |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
Unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
Volume |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes bibliographical references. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
School of Medicine |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Quality control |
| Form subdivision |
Congresses. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Standards |
| Form subdivision |
Congresses. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacopoeias |
| Form subdivision |
Congresses. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books Overnight |
